Page 282 - SRL Diagnostics

M TO R

1060 - OSTEOPORESIS MONITORING PANEL(OSTEOMON)(BETA CROSSLAPS & TOTAL P1NP)
BY ECLIA
SPECIMEN: SERUM [SAMPLES SHOULD NOT BE TAKEN  F (UP TO 2 WEEKS)
FROM PATIENTS RECEIVING THERAPY
WITH HIGH BIOTIN DOSES (I.E. > 5 MG/DAY) UNTIL AT À REPORTED ON: 2ND DAY OF
LEAST 8 HOURS
FOLLOWING THE LAST BIOTIN ADMINISTRATION] RUN
+ CLINICAL HISTORY, 2 ML
ACCEPTANCE CUT OFF: DAILY: 16:00 HRS
RUN DAY: DAILY: 16:00 HRS

1018D - OSTEOSCREEN PANEL - II (CALCIUM, PHOSPHOROUS, VITAMIN D (25 HYDROXY), PTH
INTACT, OSTEOCALCIN, ALKALINE PHOSPHATASE)
BY CHEMILUMINESCENCE / RADIOIMMUNOASSAY / SPECTROPHOTOMETRY
SPECIMEN: SERUM (A) + SERUM (F) + EDTA PLASMA (F)  SERUM AND PLASMA F; 2-8°C (2
(FROZEN SERUM, 1 ML (0.5 ML), 1 ML (0.1 ML) + 2 ML (1 ML) DAYS); F (> 2 DAYS)
ACCEPTANCE CUT OFF: DAILY: 16:00 HRS À REPORTED ON: SAME DAY OF
RUN
RUN DAY: CALCIUM, PHOSPHOROUS AND ALKALINE
PHOSPHATASE DAILY: 16:30 HRS,VIT D: DAILY: 17:30
HRS; IPTH SAT, MON, WED: 16:30HRS; OSTEOCALCIN
MON, THURS: 16:00 HRS

1017D - OSTEOSCREEN PANEL-I (CALCIUM, PHOSPHOROUS,25(OH) VIT D,IPTH)
BY CHEMILUMINESCENCE / CLIA
SPECIMEN: SERUM/EDTA PLASMA, 1 ML OF PLASMA  F
EDTA +2 ML OF SERUM
ACCEPTANCE CUT OFF: DAILY: 16:30 HRS ; PTH SAT, À REPORTED ON: SAME DAY OF
MON & WED: 16:30 HRS RUN
RUN DAY: DAILY: 16:30 HRS ; PTH SAT, MON & WED:
16:30 HRS

2361 - OVA & PARASITE - STOOL ROUTINE
BY STOOL CONCENTRATION MICROSCOPY; STAINING
SPECIMEN: STOOL, 1.0 G / 1 ML  A
ACCEPTANCE CUT OFF: DAILY: 15:30 HRS
À REPORTED ON: NEXT DAY OF
RUN DAY: DAILY: 15:30 HRS RUN

7194 - OVARIAN MALIGNANCY RISK ALGORITHM (ROMA)
BY CHEMILUMINISCENT MICROPARTICLE IMMUNOASSAY(CMIA)
SPECIMEN: SERUM (NOTE:LMP OR PRE OR POST  2-8°C (4 DAYS); -20°C (>4 DAYS)
MENOPAUSAL STATUS MANDATORY REQUIRED),
2 ML (1 ML) À REPORTED ON: SAME DAY OF
ACCEPTANCE CUT OFF: WED: 15:00 HRS RUN
RUN DAY: THURS: 15:30 HRS
270